Search
Search Results
##search.searchResults.foundPlural##
-
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3272PDF: 1336HTML: 2623 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1699PDF: 1156HTML: 243 -
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2710PDF: 1070HTML: 2565 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2585PDF: 1603HTML: 2354Table1: 188 -
WHAT ARE FUNGAL INFECTIONS?
4156PDF: 2366HTML: 27593de Pauw: 234 -
Correlation to FVIII:C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP
2219PDF: 774HTML: 853Figure 2: 213Figure 1: 166 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1554PDF: 768HTML: 1298 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1269PDF: 606HTML: 3072 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
911PDF: 489Html: 141Suppl. Files: 171 -
-
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3984PDF: 1047HTML: 3583Untitled: 174Cneo. Fig.1: 111Untitled: 102Untitled: 125Untitled: 129 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7899PDF: 4089HTML: 7344 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3530PDF: 2393HTML: 1454 -
-
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3228PDF: 931HTML: 2948 -
CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY
4166PDF: 1733HTML: 492Figure 1: Age distribution of Pediatric cases: 211 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1512PDF: 713HTML: 228 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1317PDF: 814HTML: 125 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2457PDF: 917HTML: 519 -
Screening and genetic diagnosis of Hemoglobinopathies in Southern and Northern Europe: Two examples
1140PDF: 480HTML: 1162Amato1: 164Figure 2 A: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 238jdoe, : 246Figure 2 b: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 151 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1406PDF: 926HTML: 319 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3512PDF: 1173HTML: 4997Incidence age-standardized rates for HL across the Mediterranean basin: 197 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
713PDF: 833PDF Supp. Files: 75HTML: 183







